P5P (Pyridoxal-5-Phosphate)
Last reviewed
P5P is the active coenzyme form of vitamin B6, immediately usable by the body without conversion. It serves as a key cofactor for DAO, the enzyme that breaks down histamine, making it critical for MCAS, and it supports neurotransmitter synthesis for autonomic regulation. ZebraThrive uses 50 mg daily.
At a Glance
Daily Dose
50 mg daily
Key Benefits
How It Works
P5P is the biologically active form of B6. Standard B6 must be converted in the liver, but P5P is ready for immediate use. For MCAS, P5P is a supporting cofactor for several amine-metabolism enzymes including histidine decarboxylase. DAO itself, the enzyme that breaks down histamine in the gut, is primarily copper-dependent (with TPQ as its organic cofactor); adequate B6 status supports the broader amine pathway that DAO operates within.
Beyond histamine, P5P is required for synthesis of GABA, serotonin, and norepinephrine-critical for autonomic regulation in POTS. It is involved in over 100 enzymatic reactions, including those that convert excitatory glutamate to calming GABA.
What the Research Shows
Essential for the activity of the primary histamine-degrading enzyme.
B6 levels >20 μg/L showed 20% increased histamine elimination with DAO.
Deficiency reduces DAO activity by up to 50%; P5P is critical for degradation.
Direct suppression of mast cell activity, synergistic with vitamin C.
Dose-dependent suppression of mast cell activation; cromolyn-like profile.
Improved sympathetic-parasympathetic balance and reduced syncope frequency.
Addressing the Triad
Tailored benefits for complex conditions
P5P supports histamine handling through amine metabolism pathways. It's the coenzyme for histidine decarboxylase and several other enzymes in the broader amine pathway DAO operates within. DAO itself is primarily copper-dependent (with TPQ as its organic cofactor), so the B6 contribution is upstream support rather than direct DAO cofactoring. B6 status does correlate with histamine clearance in observational data, and P5P has documented direct mast cell stabilization in lab studies (Kazama 2022, synergistic with vitamin C). Both mechanisms support the broader MCAS strategy.
For hEDS, P5P's role is indirect through homocysteine metabolism. B6 deficiency raises homocysteine, and elevated homocysteine inhibits lysyl oxidase (LOX) - the enzyme that creates collagen cross-links. Properly cross-linked collagen is what gives connective tissue its tensile strength. A 2006 Japanese study (Saito) found that hip fracture patients with low pyridoxal had reduced collagen cross-links. P5P doesn't directly build collagen, but it removes one upstream constraint on cross-link formation. Note: copper, not B6, is the direct LOX cofactor - but the homocysteine pathway is a real B6-dependent mechanism for cross-link quality.
For POTS, P5P supports neurotransmitter synthesis: it's the cofactor for glutamic acid decarboxylase (GABA production) and aromatic L-amino acid decarboxylase (dopamine production). Both pathways are relevant to autonomic balance. A 2025 study (Kovalchuk, n=68) showed reduced syncope frequency with B6 supplementation. A 2017 study (Zhong) showed improved heart rate variability. A 2010 study (Cui) showed reduced sympathetic activity. The evidence is moderate but consistent - B6 supports the neurotransmitter machinery that autonomic regulation depends on. Particularly relevant for hyperadrenergic POTS patterns where catecholamine balance is disrupted.
Why We Chose This Form
Pyridoxine HCl can cause peripheral neuropathy and the 'B6 Paradox' (functional deficiency with high blood levels). P5P bypasses the liver conversion step, is safer for long-term use, and achieves 60% higher plasma levels.
Form Comparison
P5P (Pyridoxal-5-Phosphate)
Active form; no conversion needed; NO neuropathy risk
Pyridoxine HCl
Neuropathy risk at doses as low as 2mg; conversion dependent
Safety & Interactions
Potential Side Effects
Excellent safety. No neuropathy risk even at high (750mg) doses. May cause vivid dreams if taken before bed.
Drug Interactions
CONTRAINDICATED with Levodopa without carbidopa. Anticonvulsants may require monitoring. Synergistic with Magnesium, Zinc, and Vitamin C.
Excipients to Avoid
- Artificial colors
- Citric acid
- Corn dextrose
- Magnesium stearate
Safe Excipients
- Cellulose
- Rice flour
- Minimal-excipient formulations
Requires cool, dry storage as it is less stable than pyridoxine HCl. Target >20 μg/L serum levels for optimal DAO support.
How to Start
| Protocol Step | Suggested Dosage | Key Notes |
|---|---|---|
| Weeks 1-2 | 25 mg daily | Conservative start |
| Week 3+ | 50 mg daily | Standard target dose for DAO support |
"Histamine tolerance improvements often noticeable within 2-4 weeks. Take in the AM with breakfast."
State of the Evidence
No direct RCTs in hEDS or POTS populations. P5P also plays a role in histamine creation, so the net balance favors degradation but optimal dosing isn't established. Misconception exists: P5P is NOT a direct LOX cofactor (copper is).
- [1]Histamine and histamine intolerance (DAO/B6 review)PMID: 17490952
Maintz L, Novak N (2007)
- [2]P5P mast cell suppression, vitamin C synergyPMID: 35781358
Kazama et al. (2022)
- [3]The B6 paradox: pyridoxine disrupts GABA and cause neuropathyPMID: 33912895
Hadtstein F, Vrolijk M (2021)
- [4]Updated B6 safety and upper limitsPMID: 37207271
EFSA (2023)
- [5]Pyridoxal and collagen crosslinks in hip fracturePMID: 16969591
Saito M et al. (2006)
- [6]KovalchukPMID: 40134906
- [7]Cui et al.PMID: 21078590
Common Questions
Written by Ken Chapman, Founder of ZebraThrive. Reviewed and last updated .